Dr. John Catanzaro is a pioneering leader in precision molecular medicine, specializing in personalized peptide engineering, OMICS-driven bioinformatics therapeutics, and signal-based molecular interventions. He earned his Doctorate of Naturopathic Medicine from Bastyr University in 1995 and a Doctorate of Theology in Science and Medical Ethics from Bethany Divinity Seminary in 2012.
Dr Catanzaro is a Co-founder of Neo7Bioscience that birthed from his desire to help critically ill cancer patients who have exhausted traditional treatment options and are seeking alternatives. He is a relentless advocate for next-generation patient-specific therapeutics. His work bridges the frontier of cutting-edge science and transformative clinical applications, shaping the future of precision medicine through intelligent molecular signaling and redefining personalized healthcare, while adhering to the highest legal and ethical business standards.
www.neo7bioscience.com
https://www.instagram.com/in_fo7013/
https://www.instagram.com/neo7bioscience/
https://substack.com/@johncatanzaro752375
https://beyondbio.substack.com/publish/posts/published
https://x.com/Docjohnc
https://x.com/neo7bioscience
_________
To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.
To learn more about Radical Remission health coaching with Liz or Karla, Click Here
Join our mailing list and you’ll receive our free eBook, Kickstart Your Healing: 20 Radical Remission Tips, as a special thank you for joining. Subscribe Here
To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here. To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning.
Follow us on Social Media:
______
Our Sponsor:
Immunocine Cancer Center is focused on advancing personalized cancer immunotherapy by harnessing the power of the immune system.
Their work centers on the Immunocine Dendritic Cell Treatment (IDCT) — a first-in-class therapy designed to train the immune system to recognize and respond to a patient’s specific cancer. The process begins by collecting information from the patient’s tumor and using it to program specialized immune cells called dendritic cells, which help activate targeted immune responses.
A key differentiator in Immunocine’s approach is something called double loading — cancer information is delivered to the dendritic cell both inside the cell and on its surface, giving the immune system a more complete blueprint of the cancer it needs to recognize and attack. And while this approach is unique to Immunocine and unique to use therapeutically, it is NOT unique to biology - since this is how the immune system was always meant to work!
Immunocine treats patients from around the world at its clinic in Cancun, Mexico, combining advanced immune science with personalized care. As always, patients should first explore whether they may be eligible for a clinical trial in the United States. To learn more, visit Immunocine.com.
Website Links
https://immunocine.com/
Social Media
Instagram — https://www.instagram.com/immunocine/
YouTube — https://www.youtube.com/@immunocinecancercenter
Linkedin — https://www.linkedin.com/company/immunocine/
Facebook — https://www.facebook.com/Immunocine/
